Fundraising FoxDigitalDx Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Jaguar Health is a pharmaceutical company developing crofelemer, including a novel powder for oral solution formulation, for gastrointestinal conditions and rare intestinal failure indications such as microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) in adults and children.
BiotechDigital HealthHealthtechSan Francisco, US
Lisa Conte(Executive Officer, Director)Carol Lizak(Executive Officer)Pravin Chaturvedi(Executive Officer)Steven King(Executive Officer)inJonathan Wolin(Executive Officer)inSerge Martinod(Executive Officer)
Board seatAnula Jayasuriya· per SEC Form D · $10.8M raise · filed Nov 2025
Co-investorsBVCF
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia.
BiotechHealthtechWellness & FitnessWaltham, US
ILISSA LARIMORE(Executive Officer)inGERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)
BoardMATTHEW WALKER(Director)inNEAL BHADKAMKAR(Director)in
Board seatAnula Jayasuriya· per SEC Form D · filed Nov 2025
Co-investorsJoyance PartnersOlive Tree CapitalRising TideBold Capital PartnersGISEV Family OfficeS2G Investments+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.